The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Effects of 12 Months of Vagus Nerve Stimulation in Treatment-Resistant Depression: A Naturalistic Study
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
(1976) · Medical Entomology and Zoology · Cited by 8,899
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744 · cited 1×
“The 11-item Young Mania Rating Scale (Young et al 1978) was used to assess manic/hypomanic symptoms.”
MethodDevelopment of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
(1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177 · cited 1×
“…Depression Rating Scale (MADRS) (Montgomery and Asberg 1979), the Clinical Global Impression Scale (Severity – CGI-S and Improvement – CGI-I) subscales (Guy W 1976), and the 30-item Inventory of Depressive Symptomatology – Self-Report (IDS-SR30) (Rush et al 1996, 2000; 2005; Trivedi et al 2004).”
MethodSelf-citationPapageorgis, D. (1991) · Behaviour Research and Therapy · doi:10.1016/0005-7967(91)90087-j · Cited by 1,534
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076
Self-citationDistributed Disturbances in Brain Structure and Function in Schizophrenia
(2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.1 · Cited by 969
Research works printed but not linked: 3
- 2000, Practice guideline for the treatment of patients with major depressive disorder (revision), Am J Psychiatry, 157, 1
- Greden, 2001, The burden of recurrent depression, J Clin Psychiatry, 22, 5
- Linden, 1994, Structure and feasibility of a standardized stepwise drug treatment regimen (SSTR) for depressed inpatients, Pharmacopsychiatry, 1, 51, 10.1055/s-2007-1014329 · doi:10.1055/s-2007-1014329
Cited by
Bewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., Axmacher, N., Lemke, M., Cooper-Mahkorn, D., Cohen, M. X., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.013 · Cited by 865
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301131 · Cited by 707
Self-citationKennedy, S. H., Lam, R. W., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 525
Nemeroff, C. B., Mayberg, H. S., Krahl, S. E., McNamara, J., Frazer, A., Henry, T. R., George, M. S., Charney, D. S., & Brannan, S. K. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301082 · Cited by 496
“Data from the 205 patients who completed the 12-month naturalistic study (Rush et al, 2005b) were compared with a matched control group of 124 patients with treatmentresistant depression who received only TAU (George et al, 2005).”
BackgroundMethodInfluentialSelf-citation(2007) · PubMed · Cited by 453
Karavidas, M. K., Lehrer, P. M., Vaschillo, E., Vaschillo, B., Marin, H., Buyske, S., Malinovsky, I., Radvanski, D., & Hassett, A. (2007) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-006-9029-z · Cited by 440
Stuck in a rut: rethinking depression and its treatment
Holtzheimer, P. E., & Mayberg, H. S. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2010.10.004 · Cited by 430
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.770551 · Cited by 421
Quintana, D. S., Alvares, G. A., & Heathers, J. A. J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.73 · Cited by 420
“…stimulation (VNS), which involves surgical implants of electrodes to the left vagus nerve, also increases HRV. 32,33 VNS has demonstrated effectiveness in treatment-resistant depression, 34 – 37 with the US Food and Drug Administration granting approval for such therapeutic use of VNS in 2005.”
Transcutaneous Vagus Nerve Stimulation Modulates Default Mode Network in Major Depressive Disorder
Fang, J., Rong, P., Hong, Y., Fan, Y., Liu, J., Wang, H., Zhang, G., Chen, X., Shi, S., Wang, L., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.025 · Cited by 408
Bonaz, B., Sinniger, V., & Pellissier, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01452 · Cited by 405
Howland, R. H. (2014) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-014-0010-5 · Cited by 405
Self-citationGeorge, M. S., & Aston-Jones, G. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.87 · Cited by 401
Self-citationAaronson, S. T., Sears, P., Ruvuna, F., Bunker, M., Conway, C. R., Dougherty, D. D., Reimherr, F. W., Schwartz, T. L., & Zajecka, J. M. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16010034 · Cited by 381
Self-citationGeorge, M. S., Rush, A. J., Marangell, L. B., Sackeim, H. A., Brannan, S. K., Davis, S. M., Howland, R., Kling, M. A., Moreno, F., Rittberg, B., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.028 · Cited by 372
Self-citationMcGrath, P. J., Stewart, J. W., Fava, M., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Thase, M. E., Davis, L., Biggs, M. M., Shores-Wilson, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1531 · Cited by 350
Self-citationBen‐Menachem, E., Revesz, D., Simon, B. J., & Silberstein, S. (2015) · European Journal of Neurology · doi:10.1111/ene.12629 · Cited by 344
Huston, J. M., & Tracey, K. J. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02321.x · Cited by 339
Rong, P., Liu, J., Wang, L., Liu, R., Fang, J., Zhao, J., Zhao, Y., Wang, H., Vangel, M., Sun, S., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.031 · Cited by 297
Koenig, J., Kemp, A. H., Beauchaine, T. P., Thayer, J. F., & Kaess, M. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.04.013 · Cited by 285
McAllister-Williams, R. H., Arango, C., Blier, P., Demyttenaere, K., Falkai, P., Gorwood, P., Hopwood, M., Javed, A., Kasper, S., Malhi, G. S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.023 · Cited by 278
Self-citationA pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders
George, M. S., Ward, H. E., Ninan, P. T., Pollack, M., Nahas, Z., Anderson, B., Kose, S., Howland, R. H., Goodman, W. K., & Ballenger, J. C. (2008) · Brain Stimulation · doi:10.1016/j.brs.2008.02.001 · Cited by 251
Self-citationTreatment-resistant depression and suicidality
Bergfeld, I. O., Mantione, M., Figee, M., Schuurman, P. R., Lok, A., & Denys, D. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.016 · Cited by 256
Conway, C. R., George, M. S., & Sackeim, H. A. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.2586 · Cited by 244
Self-citationRole of the vagus nerve in the development and treatment of diet‐induced obesity
de Lartigue, G. (2016) · The Journal of Physiology · doi:10.1113/jp271538 · Cited by 238
Vagus nerve stimulation: a new promising therapeutic tool in inflammatory bowel disease
Bonaz, B., Sinniger, V., & Pellissier, S. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12611 · Cited by 213
Vagus nerve stimulation for depression: efficacy and safety in a European study
Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., Heuser, I., Bajbouj, M., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2008) · Psychological Medicine · doi:10.1017/s0033291707001924 · Cited by 205
Two-year outcome of vagus nerve stimulation in treatment-resistant depression
Bajbouj, M., Merkl, A., Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181db8831 · Cited by 178
Review of the Uses of Vagal Nerve Stimulation in Chronic Pain Management
Chakravarthy, K., Chaudhry, H., Williams, K., & Christo, P. J. (2015) · Current Pain and Headache Reports · doi:10.1007/s11916-015-0528-6 · Cited by 172
Daban, C., Martinez-Aran, A., Cruz, N., & Vieta, E. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.02.012 · Cited by 163
Olin, B., Berry, Broglio, Bunker, Jayewardene, & Rush (2013) · Medical Devices: Evidence and Research · doi:10.2147/mder.s41017 · Cited by 152
Vagus Nerve Stimulation for Epilepsy and Depression
Milby, A. H., Halpern, C. H., & Baltuch, G. H. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2007.10.071 · Cited by 141
“of active VNS revealed favorable response and remission rates consistent with previous pilot studies.(89,90)”
ResultVagus nerve stimulation in psychiatry: a systematic review of the available evidence
Cimpianu, C.-L., Strube, W., Falkai, P., Palm, U., & Hasan, A. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1642-2 · Cited by 138
Furmaga, H., Shah, A., & Frazer, A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.020 · Cited by 116
Kemp, A. H., Koenig, J., & Thayer, J. F. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.006 · Cited by 114
Sackeim, H. A., Aaronson, S. T., Bunker, M. T., Conway, C. R., Demitrack, M. A., George, M. S., Prudic, J., Thase, M. E., & Rush, A. J. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.03.021 · Cited by 109
Self-citationMartin, J. L. R., & Martín-Sánchez, E. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.07.006 · Cited by 102
“Yet, when the stimulation was activated in both groups (VNS and sham), with the aim of conducting an open, longterm, follow-up study, a response was observed in 55 subjects (27%) at one year of treatment [43].”
BackgroundMethodInfluentialSomatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS
Cusin, C., & Dougherty, D. D. (2012) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-2-14 · Cited by 98
“However, follow-up observations of this cohort suggested a cumulative beneficial effect of treatment over time, reaching response rates between 27% and 34% and remission of 15% at one year [45], with similar outcomes for patients with MDD and BP depression [46].”
ResultPardo, J. V., Sheikh, S. A., Schwindt, G. C., Lee, J. T., Kuskowski, M. A., Surerus, C., Lewis, S. M., Abuzzahab, F. S., Adson, D. E., & Rittberg, B. R. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.267 · Cited by 79
Self-citationThe antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies
Grimonprez, A., Raedt, R., Baeken, C., Boon, P., & Vonck, K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.019 · Cited by 81
Conway, C. R., Chibnall, J. T., Gebara, M. A., Price, J. L., Snyder, A. Z., Mintun, M. A., Craig, A. D. (., Cornell, M. E., Perantie, D. C., Giuffra, L. A., et al. (2013) · Brain Stimulation · doi:10.1016/j.brs.2012.11.006 · Cited by 75
“[4] found that 15% of TRMD patients responded to VNS at 3 months,18% at 6 months, 23% at 9 months, and 30% at 12 months.”
BackgroundSelf-citationPerez, S. M., Carreno, F. R., Frazer, A., & Lodge, D. J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0588-14.2014 · Cited by 65
Christmas, D., Steele, J. D., Tolomeo, S., Eljamel, M. S., & Matthews, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.080 · Cited by 57
Kumar, A., Bunker, M. T., Aaronson, S. T., Conway, C. R., Rothschild, A. J., Mordenti, G., & Rush, A. J. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s196665 · Cited by 44
“The standard threshold for defining TRD in the VNS trials is failure of four adequate prior antidepressant treatments, although there is currently not a complete consensus on the required number of medication failures.7 Several reports have found either an earlier or more frequent benefit (in both response or remissio…”
BackgroundResultInfluentialSelf-citationA Systematic Review of Neuromodulation Treatment Effects on Suicidality
Kucuker, M. U., Almorsy, A. G., Sonmez, A. I., Ligezka, A. N., Doruk Camsari, D., Lewis, C. P., & Croarkin, P. E. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.660926 · Cited by 25
Kalkman, H. O. (2023) · Biomedicines · doi:10.3390/biomedicines11030806 · Cited by 18
Sackeim, H. A., Dibué, M., Bunker, M. T., & Rush, A. J. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s286977 · Cited by 15
Self-citationKraus, C., Quach, D., Sholtes, D. M., Kavakbasi, E., De Zwaef, R., Dibué, M., Zajecka, J., & Baune, B. T. (2022) · Neuromodulation: Technology at the Neural Interface · doi:10.1016/j.neurom.2021.12.010 · Cited by 14
Metadata
- Authors
- Rush, A. J., Sackeim, H. A., Marangell, L. B., George, M. S., Brannan, S. K., Davis, S. M., Lavori, P., Howland, R., Kling, M. A., Rittberg, B., Carpenter, L., Ninan, P., Moreno, F., Schwartz, T., Conway, C., Burke, M., & Barry, J. J.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 58
- Issue
- 5
- Pages
- 355-363
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2073253997
- Cited by
- 400
- References
- 39
- FWCI
- 17.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.